FX.co ★ Pfizer Chief Scientific Officer Mikael Dolsten To Step Down

Pfizer Inc. (PFE) announced on Tuesday that Mikael Dolsten will resign from his positions as Chief Scientific Officer and President of Pfizer Research & Development. However, Dolsten will remain in his current role until a successor is named.

The pharmaceutical company will commence an external search for a new chief scientific officer, a process anticipated to continue into early next year.

Meanwhile, Pfizer's stock is currently down by 1.84 percent, trading at $27.42 on the New York Stock Exchange.